Kallikrein 4 overexpression in endometrial carcinoma and upregulation by estrogen via mitogen-activated protein kinase signal pathway.

Int J Gynecol Cancer

Department of Obstetrics and Gynecology, Affiliated First People's Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China.

Published: November 2009

Objective: The aim of this study was to investigate the expression of kallikrein 4 (KLK4) and the potential signal pathway through which estrogen up-regulates KLK4 in endometrial cancer.

Methods: The expression of KLK4 was analyzed in 15 human normal endometrium, 13 hyperplasia endometrium, and 68 endometrioid adenocarcinoma by immunohistochemistry. After exposure to 17beta-estradiol and/or to the mitogen-activated protein kinase (MAPK) inhibitor U0126 and to the PI3K inhibitor LY294002, the expression of KLK4 in the endometrial cancer cell lines KLE and RL95-2 was detected with quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) and Western blot.

Results: The expression of KLK4 protein was higher in endometroid endometrial cancer than in hyperplasia or normal endometrium (P < 0.001). Immunohistochemical staining revealed that 92.6% (63/68) of endometrial adenocarcinoma, 61.5% (8/13) of hyperplasia endometrium, and 26.7% (4/15) of normal endometrium were positive for KLK4 protein. The expression of KLK4 was significantly associated with tumor grade (P = 0.004), but not with ER status (P = 0.532). Quantitative reverse transcriptase PCR and Western blot analysis showed that estrogen can up-regulate the expression of KLK4 in endometrial cancer cell lines KLE and RL95-2, and the up-regulation effect of 17beta-estradiol on KLK4 can be inhibited by U0126 in the 2 endometrial cancer cell lines but not by LY294002.

Conclusions: Kallikrein 4 is a new nuclear protein, and estrogen up-regulates the expression of KLK4 by activating the MAPK pathway in endometrial cancer cell lines, which may play an important role in the development of endometrial cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1111/IGC.0b013e3181a83e1aDOI Listing

Publication Analysis

Top Keywords

expression klk4
24
endometrial cancer
24
cancer cell
16
cell lines
16
klk4 endometrial
12
normal endometrium
12
klk4
10
endometrial
9
mitogen-activated protein
8
protein kinase
8

Similar Publications

Metabolic remodeling in glioblastoma: a longitudinal multi-omics study.

Acta Neuropathol Commun

October 2024

INSERM U1245, Department of Metabolic Biochemistry, Normandie Univ, UNIROUEN, CHU Rouen, 76000, Rouen, France.

Monitoring tumor evolution and predicting survival using non-invasive liquid biopsy is an unmet need for glioblastoma patients. The era of proteomics and metabolomics blood analyzes, may help in this context. A case-control study was conducted.

View Article and Find Full Text PDF
Article Synopsis
  • * Data from 2,500 infertile males were reviewed, narrowing it down to 198 cases with chromosomal abnormalities; most commonly observed were reciprocal translocations, with notable frequencies on chromosomes 13, 14, and 1.
  • * The research suggested that certain breakpoints might be associated with different types of infertility, and identified 19 genes with significant expression changes in azoospermic patients, indicating their relevance to male infertility.
View Article and Find Full Text PDF

Esophageal cancer is a major global health challenge with a poor prognosis. Recent studies underscore the extracellular matrix (ECM) role in cancer progression, but the full impact of ECM-related genes on patient outcomes remains unclear. Our study utilized next-generation sequencing and clinical data from esophageal cancer patients provided by The Cancer Genome Atlas, employing the R package in RStudio for computational analysis.

View Article and Find Full Text PDF

The role of miR-765 in human cancers.

Int Immunopharmacol

September 2024

Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, P.O.Box 11099, Taif 21944, Saudi Arabia.

MicroRNAs, a collection of short noncoding RNAs, are promising biomarkers for identifying cancer in its early stages and tracking the effectiveness of treatment. This is due to their critical role in regulating gene expression and other vital biological functions via cell-level epigenetic mechanisms. This review brings together data on the molecular and clinical effects of miR-765 on different types of cancer.

View Article and Find Full Text PDF

Hypoxic Regulation of the KLK4 Gene in two Different Prostate Cancer Cells Treated with TGF- β.

Cell Biochem Biophys

September 2024

University of Balikesir, Faculty of Science and Literature, Department of Molecular Biology and Genetics, Balikesir, Turkey.

The human kallikrein-related peptidase (KLK) family which consists of 15 members is associated with prostate cancer and other cancers. It has been reported that overexpression of KLK4 in prostate cancer correlates with bone metastasis or advanced stage. Hypoxia occurs in the early stages of prostate cancer due to the accumulation of acidic metabolites or reactive oxygen species (ROS).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!